I am excited that the UK appears to be moving swiftly to evaluate Leronlimab for approval in the UK. I dont want to get ahead of myself and assume that they have already reviewed data and are leaning toward approval however.

Does anyone have any insight as to the potential timeframes?

If we get the documentation into to MHRA, it sounded like we would have a 1 hour teleconference on or about 9/9?

Does anyone know what the next steps would be?